Biogen Inc (NASDAQ:BIIB)

291.44
Delayed Data
As of Dec 06
 -1.22 / -0.42%
Today’s Change
187.16
Today|||52-Week Range
311.88
+21.47%
Year-to-Date

Stock Price Forecast

The 26 analysts offering 12-month price forecasts for Biogen Inc have a median target of 325.00, with a high estimate of 370.00 and a low estimate of 247.00. The median estimate represents a +11.52% increase from the last price of 291.44.

Analyst Recommendations

The current consensus among 33 polled investment analysts is to Buy stock in Biogen Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$3.48
Sales
$2.4B
Reporting Date
Feb 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -26.95%
 
 
 
 
 
 
Growthannually -11.15%
 
 
 
 
 
 

Sales

Growthquarterly -2.51%
 
 
 
 
 
 
Growthannually -8.29%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.